Literature DB >> 11466560

Angiotensin II induces p27(Kip1) expression in renal tubules in vivo: role of reactive oxygen species.

G Wolf1, U Wenzel, T Hannken, R A Stahl.   

Abstract

Previous studies have demonstrated that angiotensin II (ANG II) mediates cell cycle arrest of cultured renal tubular cells by induction of p27(Kip1), an inhibitor of cyclin-dependent kinases. However, it is not known whether ANG II exerts similar effects in vivo. Infusion of ANG II into naive rats for 7 days increased formation of reactive oxygen species in tubular cells of the kidney. Furthermore, ANG II infusion stimulated protein expression of p27(Kip1) as detected by western blotting of tubular lysates and immunohistochemistry. Infusion of ANG II reduced tubular proliferation as detected by proliferating-cell nuclear antigen (PCNA) immunohistochemistry. The increase in p27(Kip1) expression was not due to an increase in mRNA. Immunoprecipitation experiments revealed that the increased p27(Kip1) protein associates with cyclin-dependent kinase 2. Coadministration of the radical scavenger dimethylthiourea abolished this ANG II mediated p27(Kip1) expression without reducing systemic blood pressure. Furthermore, dimethylthiourea infusion attenuates the ANG II mediated G(1)-phase arrest of tubular cells. However, infusion of norepinephrine did not induce reactive oxygen species or p27(Kip1) expression, despite a significant increase in blood pressure. Thus ANG II induces p27(Kip1) expression in renal tubular cells in vivo. This effect is mediated by reactive oxygen species. Since tubular hypertrophy depends on G(1)-phase arrest and may promote subsequent development of interstitial fibrosis, administering oxygen radical scavenger may be a therapeutic tool to counteract ANG II dependent remodeling of renal tubular cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11466560     DOI: 10.1007/s001090100241

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  7 in total

1.  Angiotensin II and cell cycle inhibition.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2001-07       Impact factor: 4.599

2.  p21(Cip1) expression is increased in ambient oxygen, compared to estimated physiological (5%) levels in rat muscle precursor cell culture.

Authors:  S J Lees; T E Childs; F W Booth
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

3.  Mycophenolate mofetil inhibits hypertrophy and apoptosis of podocyte in vivo and in vitro.

Authors:  Wei Lv; Jingqiu Lou; Yan Zhang; Peiwen Lian; Dong Qi; Jianping Wang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Quantification of angiotensin II-regulated proteins in urine of patients with polycystic and other chronic kidney diseases by selected reaction monitoring.

Authors:  Ana Konvalinka; Ihor Batruch; Tomas Tokar; Apostolos Dimitromanolakis; Shelby Reid; Xuewen Song; York Pei; Andrei P Drabovich; Eleftherios P Diamandis; Igor Jurisica; James W Scholey
Journal:  Clin Proteomics       Date:  2016-08-05       Impact factor: 3.988

5.  Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells.

Authors:  Sybille Franke; Manfred Sommer; Christiane Rüster; Tzvetanka Bondeva; Julia Marticke; Gunther Hofmann; Gert Hein; Gunter Wolf
Journal:  Arthritis Res Ther       Date:  2009-09-07       Impact factor: 5.156

Review 6.  Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?

Authors:  Speranza Rubattu; Silvia Mennuni; Marco Testa; Mara Mennuni; Giorgia Pierelli; Beniamino Pagliaro; Erica Gabriele; Roberta Coluccia; Camillo Autore; Massimo Volpe
Journal:  Int J Mol Sci       Date:  2013-11-20       Impact factor: 5.923

Review 7.  Angiotensin converting enzyme 2 in the kidney.

Authors:  A Koitka; M E Cooper; M C Thomas; C Tikellis
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-04       Impact factor: 2.557

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.